|
|
||||||||
Published online before print July 15, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
The Center for Immunology and the Departments of Veterinary PathoBiology and Laboratory Medicine and Pathology, University of Minnesota Academic Health Center, University of Minnesota, St. Paul
@ To whom correspondence should be addressed. E-mail: walch003{at}umn.edu.
| Abstract |
|---|
L-selectin is expressed by leukocytes and facilitates their adhesion under flow along the walls of blood vessels. As do a variety of membrane proteins, L-selectin undergoes ectodomain shedding. Using approaches that monitor full-length L-selectin in short-term assays, it has been determined that L-selectin shedding is defective in tumor necrosis factor
-converting enzyme (ADAM-17)-deficient cells. In this study, we examined the steady-state levels of L-selectin on ADAM-17-deficient cells using a monoclonal antibody to the cytoplasmic region of L-selectin, which allows for the detection of total L-selectin (full-length and the membrane-associated cleavage fragment). We demonstrate that ADAM-17-deficient cells generate a 6-kDa transmembrane fragment of L-selectin. Although inducible L-selectin shedding by phorbol 12-myristate 13-acetate stimulation was not observed by these cells in short-term assays, basal turnover did occur, resulting in the production of soluble L-selectin, as determined by enzyme-linked immunosorbent assay. L-selectin turnover was greatly increased upon ADAM-17 reconstitution. Truncating the juxtamembrane region of L-selectin blocked ADAM-17-independent shedding as did a hydroxymate metalloprotease inhibitor. Together, these findings demonstrate that a metalloprotease activity separate from ADAM-17 can use the cleavage domain of L-selectin. We speculate that separate proteolytic mechanisms of L-selectin shedding may regulate distinct antiadhesive mechanisms, such as inducible shedding for the rapid dissociation of cell-cell interactions and constitutive shedding for the homeostatic maintenance of high serum levels of soluble L-selectin, a potential adhesion buffer.
Key Words: inflammation adhesion endoproteolysis
This article has been cited by other articles:
![]() |
I. Ahrens, C. Ellwanger, B. K. Smith, N. Bassler, Y. C. Chen, I. Neudorfer, A. Ludwig, C. Bode, and K. Peter Selenium supplementation induces metalloproteinase-dependent L-selectin shedding from monocytes J. Leukoc. Biol., June 1, 2008; 83(6): 1388 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Schaff, P. E. Mattila, S. I. Simon, and B. Walcheck Neutrophil adhesion to E-selectin under shear promotes the redistribution and co-clustering of ADAM17 and its proteolytic substrate L-selectin J. Leukoc. Biol., January 1, 2008; 83(1): 99 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gomez-Gaviro, M. Dominguez-Luis, J. Canchado, J. Calafat, H. Janssen, E. Lara-Pezzi, A. Fourie, A. Tugores, A. Valenzuela-Fernandez, F. Mollinedo, et al. Expression and Regulation of the Metalloproteinase ADAM-8 during Human Neutrophil Pathophysiological Activation and Its Catalytic Activity on L-Selectin Shedding J. Immunol., June 15, 2007; 178(12): 8053 - 8063. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. Brazzell, A. Herrera, and B. Walcheck ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding Blood, October 1, 2006; 108(7): 2275 - 2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sengstake, E.-M. Boneberg, and H. Illges CD21 and CD62L shedding are both inducible via P2X7Rs Int. Immunol., July 1, 2006; 18(7): 1171 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Mattila, C. E. Green, U. Schaff, S. I. Simon, and B. Walcheck Cytoskeletal interactions regulate inducible L-selectin clustering Am J Physiol Cell Physiol, August 1, 2005; 289(2): C323 - C332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Garcia-Touchard, T. D. Henry, G. Sangiorgi, L. G. Spagnoli, A. Mauriello, C. Conover, and R. S. Schwartz Extracellular Proteases in Atherosclerosis and Restenosis Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1119 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rabie, A. Strehl, A. Ludwig, and B. Nieswandt Evidence for a Role of ADAM17 (TACE) in the Regulation of Platelet Glycoprotein V J. Biol. Chem., April 15, 2005; 280(15): 14462 - 14468. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bergmeier, C. L. Piffath, G. Cheng, V. S. Dole, Y. Zhang, U. H. von Andrian, and D. D. Wagner Tumor Necrosis Factor-{alpha}-Converting Enzyme (ADAM17) Mediates GPIb{alpha} Shedding From Platelets In Vitro and In Vivo Circ. Res., October 1, 2004; 95(7): 677 - 683. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |